WikiStock

Global Securities Firms Regulatory Inquiry App

English
Download
Home-News-

Why Pest Control Giant Rentokil's Shares Are Shooting Higher Today - Rentokil Initial (NYSE:RTO)

iconBenzinga

2024-06-12 15:24

Why Pest Control Giant Rentokil's Shares Are Shooting Higher Today - Rentokil Initial (NYSE:RTO)

  Pest control company Rentokil Initial PlcRTO shares are trading higher after activist investor Nelson Peltzs Trian Fund Management LPhas reportedly increased its stake, making it one of the top ten shareholders of the U.K.-based company.

  This move has notably revived Rentokils shares, which had previously suffered due to a post-COVID market slump.

  As of mid-morning trading in London, the companys shares were up by about 12%, valuing Rentokil at approximately £11.8 billion ($15 billion), reported Bloomberg.

  This boost comes after a challenging year where Rentokils stock value declined significantly, affected by reduced demand in the post-pandemic period, the report highligted.

  During the pandemic, Rentokil experienced a surge in business as increased hygiene awareness led to heightened demand for pest control services.

  However, as the situation normalized, the company faced a downturn, partly due to the resumption of travel, which briefly increased demand due to concerns over bed bugs in hotels.

  Trians acquisition is part of a broader strategy that has seen the firm take significant positions in other major companies, including Unilever PlcUL and Ferguson PlcFERG.

  Notably, Trian‘s involvement often precedes major strategic shifts aimed at enhancing shareholder value, as seen in its push for Ferguson’s re-listing in New York, which led to a substantial increase in its stock price.

  With a significant portion of its revenue coming from North America, Rentokils current valuation stands at about 17 times its 12-month forward earnings, per the report.

  This is considerably lower compared to its U.S. peers, indicating a potential undervaluation issue that Trian might address.

Disclaimer:The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.